Cargando…

Impact of Medication Adherence and Persistence on Clinical and Economic Outcomes in Patients with Type 2 Diabetes Treated with Liraglutide: A Retrospective Cohort Study

INTRODUCTION: Adherence to diabetes medication has been linked to improved glycemic levels and lower costs, but previous research on adherence has typically involved oral antidiabetic medication or insulin. This study examines how adherence and persistence to once-daily liraglutide impact glycemic c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buysman, Erin K., Liu, Fang, Hammer, Mette, Langer, Jakob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415988/ https://www.ncbi.nlm.nih.gov/pubmed/25832470 http://dx.doi.org/10.1007/s12325-015-0199-z

Ejemplares similares

Real-World Clinical and Economic Outcomes of Liraglutide Versus Sitagliptin in Patients with Type 2 Diabetes Mellitus in the United States
por: Li, Qian, et al.
Publicado: (2014)

Clinical Effectiveness of Liraglutide Across Body Mass Index in Patients with Type 2 Diabetes in the United States: A Retrospective Cohort Study
por: Chitnis, Abhishek S., et al.
Publicado: (2014)

Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone
por: Sullivan, Sean D, et al.
Publicado: (2009)

Real-World Cost-Effectiveness: Lower Cost of Treating Patients to Glycemic Goal with Liraglutide versus Exenatide
por: DeKoven, Mitch, et al.
Publicado: (2014)

Liraglutide Versus SGLT-2 Inhibitors in People with Type 2 Diabetes: A Network Meta-Analysis
por: Lorenzi, Maria, et al.
Publicado: (2016)

Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study
por: Hazel-Fernandez, Leslie, et al.
Publicado: (2013)

A Retrospective Database Study of Liraglutide Persistence Associated with Glycemic and Body Weight Control in Patients with Type 2 Diabetes
por: Melzer-Cohen, Cheli, et al.
Publicado: (2019)

Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon‐like peptide‐1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once‐weekly exenatide and liraglutide
por: Alatorre, Carlos, et al.
Publicado: (2017)

Evaluating the Short-Term Cost-Effectiveness of Liraglutide Versus Sitagliptin in Patients with Type 2 Diabetes Failing Metformin Monotherapy in the United States
por: Langer, Jakob, et al.
Publicado: (2013)

Characteristics and outcomes of patients with type 2 diabetes mellitus treated with canagliflozin: a real-world analysis
por: Buysman, Erin K., et al.
Publicado: (2015)

Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial)
por: Lind, Marcus, et al.
Publicado: (2015)

Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride
por: Jendle, J., et al.
Publicado: (2021)

Non-diabetic use of liraglutide
por: Verma, Abhyudaya
Publicado: (2012)

Retrospective Analysis of an Insulin-to-Liraglutide Switch in Patients with Type 2 Diabetes Mellitus
por: Bruinstroop, Eveline, et al.
Publicado: (2018)

Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review
por: Evans, Marc, et al.
Publicado: (2021)

Liraglutide in the management of type 2 diabetes
por: Wajcberg, Estela, et al.
Publicado: (2010)

Flare frequency, healthcare resource utilisation and costs among patients with gout in a managed care setting: a retrospective medical claims-based analysis
por: Jackson, Robert, et al.
Publicado: (2015)

Persistent disparities in diabetes medication receipt by socio‐economic disadvantage in Australia
por: Morton, Jedidiah I., et al.
Publicado: (2022)

Liraglutide Treatment in a Patient With HIV and Uncontrolled Insulin-Treated Type 2 Diabetes
por: Diamant, Michaela, et al.
Publicado: (2012)

Efficacy of Liraglutide in a Real-Life Cohort
por: Heymann, Anthony, et al.
Publicado: (2014)

Glycemic and Economic Outcomes in Elderly Patients with Type 2 Diabetes Initiating Dulaglutide Versus Basal Insulin in a Real-World Setting in the United States: The DISPEL-Advance Study
por: Hoog, Meredith, et al.
Publicado: (2023)

Adherence and Persistence to Medical Therapy in Glaucoma: An Overview
por: Quaranta, Luciano, et al.
Publicado: (2023)

Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
por: Hunter, Kerry, et al.
Publicado: (2012)

Adherence and Persistence with Once-Daily Teriparatide in Japan: A Retrospective, Prescription Database, Cohort Study
por: Tanaka, Ikuko, et al.
Publicado: (2013)

The association of body mass index with the risk of type 2 diabetes: a case–control study nested in an electronic health records system in the United States
por: Ganz, Michael L, et al.
Publicado: (2014)

Feasibility, Adherence and Efficacy of Liraglutide Treatment in a Sample of Individuals With Mood Disorders and Obesity
por: Cuomo, Alessandro, et al.
Publicado: (2019)

The INITIATOR Study: Pilot Data on Real-World Clinical and Economic Outcomes in US Patients with Type 2 Diabetes Initiating Injectable Therapy
por: Thayer, Sarah, et al.
Publicado: (2013)

Erratum to: Efficacy of Liraglutide in a Real-Life Cohort
por: Heymann, Anthony, et al.
Publicado: (2014)

Clinical Characteristics Associated with Adherence and Persistence in Patients with Type 2 Diabetes Mellitus Treated with Dulaglutide
por: Lee, David Seung U., et al.
Publicado: (2023)

Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review
por: Kennedy-Martin, Tessa, et al.
Publicado: (2017)

Modeling the economic impact of medication adherence in type 2 diabetes: a theoretical approach
por: Cobden, David S, et al.
Publicado: (2010)

The Impact of Socio Economic Factors on the Adherence of Patients with Gestational Diabetes Mellitus to Medical Recommendations
por: HAGHDOOST, Ali Akbar, et al.
Publicado: (2019)

Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study
por: Chinthammit, Chanadda, et al.
Publicado: (2021)

Liraglutide effect and action in diabetes-In (LEAD-In): A prospective observational study assessing safety and effectiveness of liraglutide in patients with type 2 diabetes mellitus treated under routine clinical practice conditions in India
por: Wangnoo, Subhash Kumar, et al.
Publicado: (2016)

Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease
por: Tian, Feng, et al.
Publicado: (2018)

Potential of liraglutide in the treatment of patients with type 2 diabetes
por: Deacon, Carolyn F
Publicado: (2009)

Comparative effectiveness of liraglutide in the treatment of type 2 diabetes
por: Rigato, Mauro, et al.
Publicado: (2014)

A Retrospective Audit of Type 2 Diabetes Patients Prescribed Liraglutide in Real-Life Clinical Practice
por: Mulligan, Ciara M., et al.
Publicado: (2013)

Associations of Renin‐Angiotensin System Antagonist Medication Adherence and Economic Outcomes Among Commercially Insured US Adults: A Retrospective Cohort Study
por: Campbell, Patrick J., et al.
Publicado: (2020)

Medication economic burden of antidepressant non-adherence in Spain
por: Gutiérrez-Abejón, Eduardo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tkq8dp9de6vea5kkde2u0hqauu